{
    "nct_id": "NCT03831711",
    "official_title": "A Pilot Study of 68-Ga-RM2 PET/MRI in the Evaluation of Patients With Estrogen Receptor-Positive Breast Cancer",
    "inclusion_criteria": "* ER+ breast cancer at initial diagnosis prior to surgery or at recurrence (at least one ER+ lesion based on results of biopsy).\n* Able to provide written consent\n* Karnofsky performance status of â‰¥ 50 (or Eastern Cooperative Oncology Group (ECOG)/World Health Organization (WHO) equivalent)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Less than 18 years-old at the time of radiotracer administration\n* Inability to lie still for the entire imaging time\n* Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)\n* Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance\n* Renal function impairment preventing administration of MRI contrast\n* Metallic implants (contraindicated for MRI)",
    "miscellaneous_criteria": ""
}